annual CAPEX:
$4.59B+$808.00M(+21.39%)Summary
- As of today (April 13, 2025), AZN annual capital expenditures is $4.59 billion, with the most recent change of +$808.00 million (+21.39%) on December 31, 2024.
- During the last 3 years, AZN annual CAPEX has risen by +$2.39 billion (+108.45%).
- AZN annual CAPEX is now -0.71% below its all-time high of $4.62 billion, reached on December 31, 2012.
Performance
AZN CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$955.00M-$403.00M(-29.68%)Summary
- As of today (April 13, 2025), AZN quarterly capital expenditures is $955.00 million, with the most recent change of -$403.00 million (-29.68%) on December 31, 2024.
- Over the past year, AZN quarterly CAPEX has stayed the same.
- AZN quarterly CAPEX is now -73.26% below its all-time high of $3.57 billion, reached on September 30, 2012.
Performance
AZN quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$4.59B+$9.00M(+0.20%)Summary
- As of today (April 13, 2025), AZN TTM capital expenditures is $4.59 billion, with the most recent change of +$9.00 million (+0.20%) on December 31, 2024.
- Over the past year, AZN TTM CAPEX has stayed the same.
- AZN TTM CAPEX is now -7.05% below its all-time high of $4.93 billion, reached on June 30, 2013.
Performance
AZN TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
AZN CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.4% | 0.0% | 0.0% |
| 3 y3 years | +108.5% | +75.9% | +100.8% |
| 5 y5 years | +86.4% | +75.9% | +100.8% |
AZN CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +108.5% | -40.5% | +163.1% | at high | +119.0% |
| 5 y | 5-year | at high | +108.5% | -40.5% | +170.5% | at high | +125.9% |
| alltime | all time | -0.7% | +1089.7% | -73.3% | +241.5% | -7.0% | >+9999.0% |
AstraZeneca CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $4.59B(+21.4%) | $955.00M(-29.7%) | $4.59B(+0.2%) |
| Sep 2024 | - | $1.36B(+103.3%) | $4.58B(+11.7%) |
| Jun 2024 | - | $668.00M(-58.4%) | $4.10B(+4.7%) |
| Mar 2024 | - | $1.60B(+69.7%) | $3.91B(+3.6%) |
| Dec 2023 | $3.78B(+46.9%) | $946.00M(+7.6%) | $3.78B(+11.6%) |
| Sep 2023 | - | $879.00M(+82.0%) | $3.39B(-6.4%) |
| Jun 2023 | - | $483.00M(-67.1%) | $3.62B(-1.6%) |
| Mar 2023 | - | $1.47B(+165.3%) | $3.68B(+43.1%) |
| Dec 2022 | $2.57B(+16.9%) | $554.00M(-50.1%) | $2.57B(-6.0%) |
| Sep 2022 | - | $1.11B(+104.6%) | $2.73B(+19.7%) |
| Jun 2022 | - | $543.00M(+49.6%) | $2.28B(+9.1%) |
| Mar 2022 | - | $363.00M(-49.4%) | $2.09B(-4.8%) |
| Dec 2021 | $2.20B(-15.6%) | $718.00M(+8.8%) | $2.20B(+8.4%) |
| Sep 2021 | - | $660.00M(+87.0%) | $2.03B(-2.2%) |
| Jun 2021 | - | $353.00M(-24.7%) | $2.08B(-23.1%) |
| Mar 2021 | - | $469.00M(-14.4%) | $2.70B(+3.6%) |
| Dec 2020 | $2.61B(+5.9%) | $548.00M(-22.3%) | $2.61B(+6.7%) |
| Sep 2020 | - | $705.00M(-27.8%) | $2.44B(+17.5%) |
| Jun 2020 | - | $977.00M(+159.8%) | $2.08B(+0.1%) |
| Mar 2020 | - | $376.00M(-2.3%) | $2.08B(-15.6%) |
| Dec 2019 | $2.46B(+79.4%) | $385.00M(+12.9%) | $2.46B(-1.0%) |
| Sep 2019 | - | $341.00M(-65.0%) | $2.48B(+3.0%) |
| Jun 2019 | - | $974.00M(+28.2%) | $2.41B(+34.2%) |
| Mar 2019 | - | $760.00M(+85.8%) | $1.80B(+31.1%) |
| Dec 2018 | $1.37B(-15.4%) | $409.00M(+52.0%) | $1.37B(-9.4%) |
| Sep 2018 | - | $269.00M(-25.1%) | $1.51B(-5.3%) |
| Jun 2018 | - | $359.00M(+7.5%) | $1.60B(+1.8%) |
| Mar 2018 | - | $334.00M(-39.4%) | $1.57B(-3.1%) |
| Dec 2017 | $1.62B(-30.0%) | $551.00M(+56.1%) | $1.62B(-5.3%) |
| Sep 2017 | - | $353.00M(+6.6%) | $1.71B(-0.8%) |
| Jun 2017 | - | $331.00M(-14.0%) | $1.72B(-28.0%) |
| Mar 2017 | - | $385.00M(-39.9%) | $2.39B(+3.4%) |
| Dec 2016 | $2.31B(-17.0%) | $641.00M(+75.1%) | $2.31B(+4.8%) |
| Sep 2016 | - | $366.00M(-63.4%) | $2.21B(-7.1%) |
| Jun 2016 | - | $1.00B(+227.1%) | $2.38B(+17.7%) |
| Mar 2016 | - | $306.00M(-42.8%) | $2.02B(-27.6%) |
| Dec 2015 | $2.79B(+1.3%) | $535.00M(+0.2%) | $2.79B(+2.4%) |
| Sep 2015 | - | $534.00M(-17.1%) | $2.72B(+4.6%) |
| Jun 2015 | - | $644.00M(-40.1%) | $2.60B(-16.0%) |
| Mar 2015 | - | $1.07B(+129.2%) | $3.10B(+12.6%) |
| Dec 2014 | $2.75B(+33.7%) | $469.00M(+13.0%) | $2.75B(-10.3%) |
| Sep 2014 | - | $415.00M(-63.6%) | $3.07B(-1.9%) |
| Jun 2014 | - | $1.14B(+56.6%) | $3.13B(+31.9%) |
| Mar 2014 | - | $728.00M(-7.4%) | $2.37B(+15.3%) |
| Dec 2013 | $2.06B(-55.4%) | $786.00M(+65.8%) | $2.06B(+12.1%) |
| Sep 2013 | - | $474.00M(+23.4%) | $1.84B(-62.8%) |
| Jun 2013 | - | $384.00M(-7.2%) | $4.93B(+2.1%) |
| Mar 2013 | - | $414.00M(-26.6%) | $4.83B(+4.6%) |
| Dec 2012 | $4.62B(+256.1%) | $564.00M(-84.2%) | $4.62B(+4.2%) |
| Sep 2012 | - | $3.57B(+1171.2%) | $4.43B(+301.2%) |
| Jun 2012 | - | $281.00M(+39.1%) | $1.10B(-10.0%) |
| Mar 2012 | - | $202.00M(-46.6%) | $1.23B(-5.3%) |
| Dec 2011 | $1.30B | $378.00M(+54.9%) | $1.30B(-6.4%) |
| Sep 2011 | - | $244.00M(-39.6%) | $1.39B(+1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2011 | - | $404.00M(+49.1%) | $1.37B(-5.4%) |
| Mar 2011 | - | $271.00M(-42.0%) | $1.45B(-33.6%) |
| Dec 2010 | $2.18B(+37.5%) | $467.00M(+103.9%) | $2.18B(-5.2%) |
| Sep 2010 | - | $229.00M(-52.5%) | $2.30B(-9.0%) |
| Jun 2010 | - | $482.00M(-51.9%) | $2.53B(+9.6%) |
| Mar 2010 | - | $1.00B(+71.2%) | $2.31B(+45.3%) |
| Dec 2009 | $1.59B(-60.7%) | $586.00M(+28.5%) | $1.59B(+6.2%) |
| Sep 2009 | - | $456.00M(+75.4%) | $1.49B(+11.6%) |
| Jun 2009 | - | $260.00M(-8.5%) | $1.34B(-3.4%) |
| Mar 2009 | - | $284.00M(-42.4%) | $1.39B(-65.7%) |
| Dec 2008 | $4.04B(+140.6%) | $493.00M(+63.8%) | $4.04B(+0.5%) |
| Sep 2008 | - | $301.00M(-2.0%) | $4.02B(-3.6%) |
| Jun 2008 | - | $307.00M(-89.6%) | $4.17B(-1.0%) |
| Mar 2008 | - | $2.94B(+523.8%) | $4.21B(+150.9%) |
| Dec 2007 | $1.68B(+25.4%) | $471.00M(+4.0%) | $1.68B(+12.5%) |
| Sep 2007 | - | $453.00M(+29.4%) | $1.49B(+7.4%) |
| Jun 2007 | - | $350.00M(-13.6%) | $1.39B(-11.1%) |
| Mar 2007 | - | $405.00M(+42.1%) | $1.56B(+16.7%) |
| Dec 2006 | $1.34B(+65.3%) | $285.00M(-18.6%) | $1.34B(+17.4%) |
| Sep 2006 | - | $350.00M(-33.1%) | $1.14B(+7.1%) |
| Jun 2006 | - | $523.00M(+189.0%) | $1.06B(+40.3%) |
| Mar 2006 | - | $181.00M(+108.0%) | $759.00M(-6.3%) |
| Dec 2005 | $810.00M(-23.8%) | $87.00M(-68.2%) | $810.00M(-15.0%) |
| Sep 2005 | - | $274.00M(+26.3%) | $953.00M(+2.6%) |
| Jun 2005 | - | $217.00M(-6.5%) | $929.00M(-27.7%) |
| Mar 2005 | - | $232.00M(+0.9%) | $1.28B(+20.9%) |
| Dec 2004 | $1.06B(-17.1%) | $230.00M(-8.0%) | $1.06B(-49.7%) |
| Sep 2004 | - | $250.00M(-56.4%) | $2.12B(+77.7%) |
| Jun 2004 | - | $573.00M(+5630.0%) | $1.19B(-7.9%) |
| Mar 2004 | - | $10.00M(-99.2%) | $1.29B(+0.8%) |
| Dec 2003 | $1.28B(-4.3%) | $1.28B(-290.0%) | $1.28B(-4.3%) |
| Sep 2003 | - | -$674.88M(-200.0%) | $1.34B(-3.1%) |
| Jun 2003 | - | $674.88M(-49.6%) | $1.38B(+3.2%) |
| Dec 2002 | $1.34B(-3.2%) | $1.34B(-312.0%) | $1.34B(+239.2%) |
| Sep 2002 | - | -$632.00M(-282.1%) | $395.00M(-71.6%) |
| Jun 2002 | - | $347.00M(+21.8%) | $1.39B(+4.7%) |
| Mar 2002 | - | $285.00M(-27.8%) | $1.33B(-4.3%) |
| Dec 2001 | $1.39B(-5.2%) | $395.00M(+9.1%) | $1.39B(-43.5%) |
| Sep 2001 | - | $362.00M(+27.4%) | $2.45B(+68.7%) |
| Jun 2001 | - | $284.12M(-17.4%) | $1.45B(-3.8%) |
| Mar 2001 | - | $343.88M(-76.5%) | $1.51B(+3.4%) |
| Dec 2000 | $1.46B(-2.0%) | $1.46B(-329.6%) | $1.46B(>+9900.0%) |
| Sep 2000 | - | -$636.08M(-286.3%) | $0.00(-100.0%) |
| Jun 2000 | - | $341.46M(+15.9%) | $636.08M(+115.9%) |
| Mar 2000 | - | $294.62M | $294.62M |
| Dec 1999 | $1.49B(+7.0%) | - | - |
| Dec 1998 | $1.39B(+84.3%) | - | - |
| Dec 1997 | $755.47M(+18.3%) | - | - |
| Dec 1996 | $638.76M(+48.2%) | - | - |
| Dec 1995 | $431.11M(-12.5%) | - | - |
| Dec 1994 | $492.47M(+6.4%) | - | - |
| Dec 1993 | $462.99M(+13.9%) | - | - |
| Dec 1992 | $406.47M(+5.5%) | - | - |
| Dec 1991 | $385.46M(-28.6%) | - | - |
| Dec 1990 | $540.10M | - | - |
FAQ
- What is AstraZeneca annual capital expenditures?
- What is the all time high annual CAPEX for AstraZeneca?
- What is AstraZeneca annual CAPEX year-on-year change?
- What is AstraZeneca quarterly capital expenditures?
- What is the all time high quarterly CAPEX for AstraZeneca?
- What is AstraZeneca quarterly CAPEX year-on-year change?
- What is AstraZeneca TTM capital expenditures?
- What is the all time high TTM CAPEX for AstraZeneca?
- What is AstraZeneca TTM CAPEX year-on-year change?
What is AstraZeneca annual capital expenditures?
The current annual CAPEX of AZN is $4.59B
What is the all time high annual CAPEX for AstraZeneca?
AstraZeneca all-time high annual capital expenditures is $4.62B
What is AstraZeneca annual CAPEX year-on-year change?
Over the past year, AZN annual capital expenditures has changed by +$808.00M (+21.39%)
What is AstraZeneca quarterly capital expenditures?
The current quarterly CAPEX of AZN is $955.00M
What is the all time high quarterly CAPEX for AstraZeneca?
AstraZeneca all-time high quarterly capital expenditures is $3.57B
What is AstraZeneca quarterly CAPEX year-on-year change?
Over the past year, AZN quarterly capital expenditures has changed by $0.00 (0.00%)
What is AstraZeneca TTM capital expenditures?
The current TTM CAPEX of AZN is $4.59B
What is the all time high TTM CAPEX for AstraZeneca?
AstraZeneca all-time high TTM capital expenditures is $4.93B
What is AstraZeneca TTM CAPEX year-on-year change?
Over the past year, AZN TTM capital expenditures has changed by $0.00 (0.00%)